Our main focus is to develop, manufacture and deliver innovative drugs to as many patients as possible, while minimizing our environmental footprint. As described in our sustainability report, we are pleased with our good performances in the most recent audits.
The most recent measurements showed a significant reduction in Total Energy Consumption per Employee versus baseline. In addition, the usage of energy from renewable sources and the usage of clean electricity is constantly improving.
HAS = Helsinn Advanced Synthesis SA
HBP = Helsinn Birex Pharmaceuticals Ltd.
HHC = Helsinn Healthcare SA
Our plants and our headquarters scored an important reduction in their CO2 emission.
Together with an innovative heat pump in our manufacturing site in Biasca and an ongoing project to deliver a centralized, biomass-fuelled remote heating plant, our objective is to reduce our carbon footprint to almost zero. In our USA offices, we have reduced our environmental impact by relocating to a LEED Gold building. Further, several projects are ongoing to reduce print and photocopier paper use and to increase separate collection of waste for recycling in all our offices.